Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease

Completed · Phase 2 · Has a placebo group

Conditions studied: Dry Eye

In brief

Investigate the Safety and Efficacy of Two Concentrations of DE-110 Compared to Placebo for the Treatment of Dry Eye Disease

Key facts

Study ID: NCT01239069
Run by: Santen Inc.
People needed: 140
Starts: 2010-11-01
Expected to finish: 2011-10-01
Last updated by the study team: 2014-05-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Confirmed diagnosis of dry eye
Not wear contact lenses during study
18 years or older
Understand and provide written consent
Negative pregnancy test and use acceptable method of contraception

You may not qualify if…

Use of any topical ocular medication
Any type of ocular surgery
Diagnosis of on-going ocular infection and/or allergic conjunctivitis
Uncontrolled systemic conditions/lid abnormalities
Corneal transplants
Females who are pregnant, nursing or planning a pregnancy
Participation in another drug trial concurrently or within 30 days prior to study

Where it is running

Study site — Inglewood, California, United States
Study site — Newport Beach, California, United States
Study site — Petaluma, California, United States
Study site — Torrance, California, United States
Study site — Bloomfield, Connecticut, United States
Study site — Bradenton, Florida, United States
Study site — Brooksville, Florida, United States
Study site — Largo, Florida, United States
Study site — Rosewell, Georgia, United States
Study site — Louisville, Kentucky, United States
Study site — Bangor, Maine, United States
Study site — Cleveland, Ohio, United States
Study site — San Antonio, Texas, United States
Study site — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.